Back
Kaiser Aluminum 10K Form
Sell
36
KALU
Kaiser Aluminum
Last Price:
68.16
Seasonality Move:
3.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | KALU/Kaiser Aluminum Quarterly |
2023-10-26 | 10Q | KALU/Kaiser Aluminum Quarterly |
2023-07-28 | 10Q | KALU/Kaiser Aluminum Quarterly |
2023-04-28 | 10Q | KALU/Kaiser Aluminum Quarterly |
2022-10-25 | 10Q | KALU/Kaiser Aluminum Quarterly |
2022-07-28 | 10Q | KALU/Kaiser Aluminum Quarterly |
Receive KALU News And Ratings
See the #1 stock for the next 7 days that we like better than KALU
KALU Financial Statistics
Sales & Book Value
Annual Sales: | $3.09B |
---|---|
Cash Flow: | $-17.4M |
Price / Cash Flow: | 9.3 |
Annual Sales: | $41.15 |
Price / Book: | 1.66 |
Profitability
EPS (TTM): | 2.50000 |
---|---|
Net Income (TTM): | $40.7M |
Gross Margin: | $332.1M |
Return on Equity: | 6.25% |
Return on Assets: | 1.78% |
Kaiser Aluminum Earnings Forecast
Key Kaiser Aluminum Financial Ratios
- The Gross Profit Margin over the past 33 years for KALU is 10.76%.
- The Selling, General & Administrative Expenses for KALU have been equal to 3.97% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 99.36% of Operating Income.
- The Net Earning history of KALU is 1.53% of Total Revenues.
- Per Share Earnings over the last 33 years have been positive in 13 years.
Kaiser Aluminum Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | KALU |
CUSIP: | 483007 |
Website: | kaiseraluminum.com |
Debt
Debt-to-Equity Ratio: | 1.57 |
---|---|
Current Ratio: | 2.55 |
Quick Ratio: | 1.31 |
Price-to-Earnings
Trailing P/E Ratio: | 23.41 |
---|---|
Forward P/E Ratio: | 12.2 |
KALU Technical Analysis vs Fundamental Analysis
Sell
36
Kaiser Aluminum (KALU)
is a Sell
Is Kaiser Aluminum a Buy or a Sell?
-
Kaiser Aluminum stock is rated a Sell
The current Kaiser Aluminum [KALU] share price is $68.37. The Score for KALU is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.